Johnson Research Group

Johnson Research Group

The Johnson Research Group LLC (JRG) is dedicated to providing investors with one thing – an edge. We know there’s no “holy grail” or “magic bullet” in investing. And we’re well aware that savvy investors know that, too. With that truth in mind, our mission is to create an edge so our followers can become more successful traders and investors.

How do we create that edge? With innovative research, a unique analytical approach and the experience to translate our edge into your investing success. JRG is dedicated to providing the highest-quality research and outstanding trading performance. We realize your success is our success. And we’ll do everything we can to make you a more successful investor.

JRG provides timely market commentary on stocks, ETFs and major indices as well as insight on activities in the equity options market. In addition to delivery through a number of media partnerships, JRG’s content and commentaries are also carried by major news television, on radio and in print.

JRG analysts are frequent commentators on financial markets and represent the firm at national investment conferences. The firm’s comments are regularly seen in national print media, such as Barron’s, Los Angeles Times, Washington Post, The Wall Street Journal, USA TODAY and on the AP Newswire.

In addition to being a guest on several radio shows, Mr. Johnson and other representatives appears regularly on CNBC, Bloomberg TV and Fox News Channel as an expert in the field of sentiment and investor behavior, as well as technical analysis.

Recent Articles

Take Profits on (and Short) These 3 ETFs

The market seems to have reached a tipping point, and now a few exchange-traded funds and their respective components stand out as potential short opportunities.

3 Pullback Trades to Insure Gains

Any short-term dips in the hot-running insurance sector should be considered a green light for bargain hunters.

How to Hedge This Crowded Market

Euphoric investors, low VIX readings might be signaling a crowded market. Use one or both of these ETFs to hedge against a pending correction.

3 Stocks Primed for a Short Squeeze

Despite general apathy among the shorts, a few stocks have attracted outsized crowds of bears. Here are three stocks that could get the benefit of a squeeze.

3 Healthcare Stocks About to Receive a Booster Shot

Despite the impressive performance of healthcare stocks as a whole, many aren't getting much analyst love. But these three will -- and when they do, look out!